Press release
Originator Small Molecule Drug Market Outlook Exhibits Sustained Growth during the Period 2018-2028
Fact.MR
Ask our Industry Expert on this Report- https://www.factmr.com/connectus/sample?flag=AE&rep_id=1519
Originator small molecule drugs are used to treat various diseases that are termed as dreaded in the recent time, e.g., cancer, diabetes, epilepsy, etc. Though biologics have impregnable efficacy as compared to originator small molecule drugs, long-term usage of biologics causes tolerance to the particular drug. The diverse usage of originator small molecule drugs range from chronic diseases such as cancer and diabetes to more humane ailments such as cold, fever and cough. Usage of small molecule drugs such as aspirin ranges from daily pains and aches to cancer treatment, Alzheimer’s disease, and cardiovascular health. Aspirin was an originator small molecule drug patented under Kaiser.
Originator Small Molecule Drug Market: Drivers and Restraints
The diverse usage of originator small molecule drugs in the recent times has put them in a good shape and are being studied for different usages, e.g. Vertex Pharmaceuticals’ Ivacaftor is the first originator small molecule drug for the treatment of protein malfunctioning caused by the genetic defect in cystic fibrosis patients. Diverse availability of dosage form for administration depending on the age of patient is a major factor driving the growth of the originator small molecule drugs market. Originator small molecule drugs are easy produce, highly profitable and scalable when compared to biologics. On an average originator small molecule drug costs US$ 1/day to produce, whereas biologics roughly costs US$ 22/day to produce. In 2017, FDA has approved total 28 originator small molecule drugs (new molecular entities), which shows the extent of ongoing research on originator small molecule drugs. Whereas in the current scenario, biologics are in trend for treatment of dreaded diseases such as cancer and diabetes due to their higher efficacy, which is expected to restrain the growth of the originator small molecule market.
Originator Small Molecule Drug Market: Overview
The originator small molecule drug market is expected to have significant growth as most of the pharmaceutical companies are investing highly on research and development of novel drug formulation for the treatment of complex diseases. Higher focus on manufacturing innovative drugs is expected to contribute significantly to the growth of the originator small molecule drug market. By drug class, the originator small molecule drug market is expected to be dominated by anti-cancer drugs segment. By indication type, the oncology segment expected to dominate the originator small molecule drug market. Whereas, by distribution channel, the retail pharmacies segment is expected to dominate the originator small molecule drug market over the forecast period.
To know more about the Originator Small Molecule Drug Market Trends, Visit the link – https://www.factmr.com/report/1519/originator-small-molecule-drug-market
Originator Small Molecule Drug Market: Regional Outlook
The global originator small molecule drug market is expected to be dominated by North America due to favorable reimbursements. Europe is expected to be the second large market for originator small molecule drugs. Asia-Pacific is expected to be the emerging market for originator small molecule drug due to affordability and reimbursement scenarios. The Middle East and Africa is expected to have sluggish growth in the global originator small molecule drug market.
Originator Small Molecule Drug Market: Key Players
Examples of some of the key participants operating in the global originator small molecule drug market are Novartis AG, Roche, Glaxosmithkline Plc., Boehringer Ingelheim International GmbH, Genentech, Amgen, Inc., Gilead, and Bristol-Myers Squibb Company, among others.
The report is a compilation of first-hand information, qualitative and quantitative assessment by industry analysts, inputs from industry experts and industry participants across the value chain. The report provides in-depth analysis of parent market trends, macro-economic indicators and governing factors along with market attractiveness as per segments. The report also maps the qualitative impact of various market factors on market segments and geographies.
The report covers exhaustive analysis on:
• Market Segments
• Market Dynamics
• Market Size
• Supply & Demand
• Current Trends/Issues/Challenges
• Competition & Companies involved
• Technology
• Value Chain
Regional analysis includes
• North America (U.S., Canada)
• Latin America (Mexico, Brazil)
• Western Europe (Germany, Italy, U.K, Spain, France, Nordic countries, BENELUX)
• Eastern Europe (Russia, Poland, Rest Of Eastern Europe)
• Asia Pacific Excluding Japan (China, India, Australia & New Zealand)
• Japan
• Middle East and Africa (GCC, S. Africa, Rest Of MEA)
Report Highlights:
• Detailed overview of parent market
• Changing market dynamics in the industry
• In-depth market segmentation
• Historical, current and projected market size in terms of volume and value
• Recent industry trends and developments
• Competitive landscape
• Strategies of key players and products offered
• Potential and niche segments, geographical regions exhibiting promising growth
• A neutral perspective on market performance
• Must-have information for market players to sustain and enhance their market footprint
Request Brochure of this Report- https://www.factmr.com/connectus/sample?flag=B&rep_id=1519
About FactMR
FactMR is a fast-growing market research firm that offers the most comprehensive suite of syndicated and customized market insights reports. We believe transformative intelligence can educate and inspire businesses to make smarter decisions. We know the limitations of the one-size-fits-all approach; that's why we publish multi-industry global, regional, and country-specific research reports.
Contact Us
FactMR
11140 Rockville Pike
Suite 400
Rockville, MD 20852
United States
Email: sales@factmr.com
Web: https://www.factmr.com/
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Originator Small Molecule Drug Market Outlook Exhibits Sustained Growth during the Period 2018-2028 here
News-ID: 1187549 • Views: …
More Releases from Fact.MR
Tech Support Services Market is Expected to reach US$ 111 Billion by 2033
The global tech support services market is estimated to be valued US$ 66.3 billion in fiscal year 2023, up from US$ 63 billion in FY2022. From 2023 to 2033, the market is predicted to increase at a 5.3% CAGR, reaching $111 billion by the end of 2033.
The market is growing as a result of increased digital technology utilization in a range of end-use industries, as well as rising social media,…
Dairy Stabilizer Market Forecasted to Achieve US$ 134 Million by 2034
The global dairy stabilizer market is expected to generate $81 million in sales in 2024 and grow to $134 million by the end of 2034. Global demand for dairy stabilizers is expected to increase at a 5.1% CAGR over the next ten years.
Dairy stabilizers are special ingredients used in the dairy industry to improve the texture and quality of products like yogurt, ice cream, and cheese. They make sure the…
Disposable Cutlery Market Projected to Reach $2.6 Billion with 4.9% CAGR by 2033
The global disposable cutlery market is expected to grow at a CAGR of 4.9%, reaching $2.6 million by the end of 2033.
Disposable cutlery refers to utensils such as forks, knives, and spoons that are designed for single use and are often composed of plastic or biodegradable materials. They're ideal for events, takeaway dinners and on-the-go eating, as they're easier to clean and transport than traditional silverware. They are especially beneficial…
Remote Control Market Projected to Reach US$ 42.1 Billion by 2034, Growing at a …
As of right now, estimates place the size of the global remote control market at a 4.8% compound annual growth rate (CAGR) over the following ten years, rising from US$ 26.4 billion in 2024 to US$ 42.1 billion by 2034.
Sales of remote controls are expected to increase gradually between 2024 and 2034 as a result of product technical developments and market participants' calculated moves. Businesses have a rare chance to…
More Releases for Originator
Originator Small Molecule Drug Market In-depth Analysis of Key Players, Growth, …
Evolving need for drug targets to treat cancer, epilepsy, diabetes and various other dreaded diseases is set to provide lucrative opportunity for small molecule drug demand. The use of diverse originator small molecule drugs varying from different humane ailments such as cold, cough and fever to attract huge customer engagement and make market get propelled.
The Market Research Survey by “Fact.MR, A Market Research and Competitive Intelligence Provider” highlights the key…
Research & Development Expenditure On Healthcare Bolster Demand Of Anti-cancer O …
The latest Fact.MR Report on Anti-cancer Originator Small Molecule Drug Market gives a 360-degree view of this market. It provides reliable data on drivers, restraints, challenges, and opportunities in the market for Anti-cancer Originator Small Molecule Drug Market.
This aside, the report gives a clear idea on the demands and consumption of diverse products/services related to the growth dynamics of the Keyword market during the Forecast period of 2021 to…
Originator Small Molecule Drug Market Future Innovation Strategies, Profit Analy …
Transportation restrictions and stringent government policies are causing a downturn in the growth scale of the Originator Small Molecule Drug market amidst the COVID-19 (Coronavirus) lockdown period.
Technology has gained so much impetus today that is has become the fulcrum of several industries today.
Edge computing is making headlines as cloud computing and artificial intelligence begin to disrupt the technology industry.
To get in-depth information view the report – https://www.factmr.com/report/1519/originator-small-molecule-drug-market
It not only…
Global Rituximab Biosimilar Market Assessment –Clinical Trial/Pipeline Analysi …
InsightAce Analytic Pvt. Ltd. announces the release of market assessment report on 'Global Rituximab Biosimilar Market Assessment – Revenue Forecast, Clinical Trial/Pipeline Analysis, Brand/Originator Drug Historic Revenue and Forecast Till 2027'
Request for ToC/Proposal: https://bit.ly/2llXAAD
Rituximab is a chimeric anti-CD20 antibody that binds to the CD20 antigen present on the normal and malignant B cells surface. It is indicated for the treatment of blood cancer (CD20-positive) such as chronic lymphocytic leukemia and…
Originator Small Molecule Drug Market- Key Players | Novartis AG, Roche, Glaxosm …
Small molecule drugs are the ones with low molecular weight, generally less than 900 daltons. 90% of the drugs in the market are small molecule drugs of which 50% are derived from pre-existed metabolites and 30% of genetic disorder. Since small molecule drugs have low molecular weight, they are easily absorbable and can pass through the cell membrane.
Due to low molecular weight, small molecule drugs can travel to the desired…
Originator Small Molecule Drug Market Trends, Regulations And Competitive Landsc …
Small molecule drugs are the ones with low molecular weight, generally less than 900 daltons. 90% of the drugs in the market are small molecule drugs of which 50% are derived from pre-existed metabolites and 30% of genetic disorder. Since small molecule drugs have low molecular weight, they are easily absorbable and can pass through the cell membrane. Due to low molecular weight, small molecule drugs can travel to the…
